Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-transplant maintenance with lenalidomide/dexamethasone with or without ixazomib in newly diagnosed multiple myeloma
2014-000554-10Phase 3Completed
- Sponsor
- Fundación PETHEMA
- Start
- May 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in multiple myeloma (MM) comparing Lenalidomide + dexamethasone maintenance with Lenalidomide + dexamethasone + ixazomib maintenance (2 arms). Primary endpoint: Progression-free survival. Started May 2014; status: completed.
02
Drugs
lenalidomidedexamethasoneixazomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2014-000554-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000554-10.